Skip to main content

9 Result(s)

within C. Pouteil-Noble Remove this filter

and

  1. No Access

    Chapter

    Transplantation versus dialysis in aged and type II diabetic patients

    In the early years of dialysis, the majority of patients accepted for a renal replacement therapy were men, diabetics were never treated and patients were not accepted beyond age 55. Nowadays, diabetes is the ...

    C. Pouteil-Noble, E. Villar, D. Babici… in Transplantation and Changing Management of… (2000)

  2. No Access

    Chapter

    Questions raised by the exclusion of ‘at risk’ conditions from current trials in organ transplantation

    The recent development of new immunosuppressive agents may improve the overall results of organ transplantation and open new areas for clinical applications of allografts. The introduction of cyclosporin A 20 ...

    J. P. Revillard, C. Pouteil-Noble, P. Cochat in Immunosuppression under Trial (1999)

  3. No Access

    Chapter

    Is there any relationship between the early glomerular filtration rate and late graft dysfunction in renal transplantation?

    Late graft dysfunction remains the main cause of graft loss in renal transplantation in spite of improvements in shortterm renal allograft survival and advances in immunosuppressive therapy [1]. Chronic reject...

    C. Pouteil-Noble, L. Remontet, M. Lombardo, J. L. Touraine… in Late Graft Loss (1997)

  4. No Access

    Chapter and Conference Paper

    Skin Cancers in Organ Transplant Recipients

    Skin cancers especially squamous cell carcinomas (SCC) are the most frequent malignancies in organ transplant recipients; they are often preceded by viral warts and solar keratoses and represent a model of vir...

    S. Euvrard, J. Kanitakis, C. Pouteil-Noble, Y. Chardonnet… in Skin Cancer and UV Radiation (1997)

  5. No Access

    Chapter

    Combined Kidney Transplantation (Tx) with Heart, Liver or Pancreas

    Surgical technologies and immunosuppressive treatment refinment allow to practice simultaneous or differed multiple Tx for a same patient (pt).

    A. C. Marrast, J. L. Touraine, J. M. Dubernard, G. Dureau… in Organ Shortage: The Solutions (1995)

  6. No Access

    Chapter

    Can we select candidates for combined kidney and heart or liver transplantation?

    A better understanding of diseases such as primary hyperoxaluria and multiorgan failure have led to the performance of combined organ transplantation. We present here the indications and results of combined ki...

    J. L. Garnier, A. C. Marrast, C. Pouteil-Noble, X. Martin… in Organ Shortage: The Solutions (1995)

  7. No Access

    Chapter and Conference Paper

    Should hepatitits-C virus antibody-positive donors be excluded from kidney donation?

    In organ transplantation, virus transmitted by the donor is associated with a higher risk of severe primary infection after transplantation in the seronegative recipient. In this study, the risk of hepatitis-C...

    C. Pouteil-Noble, J. L. Touraine… in Transplant International Official Journal … (1992)

  8. No Access

    Chapter and Conference Paper

    Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation

    The aim of the study was to evaluate the virological parameters associated with the severity of cytomegalovirus (CMV) disease in renal and simultaneous renal and pancreatic transplantation. The association of ...

    C. Pouteil-Noble, B. Lacavalerie, A. Donia… in Transplant International Official Journal … (1992)

  9. No Access

    Article

    The place of fetal liver transplantation in the treatment of inborn errors of metabolism

    Over the last 16 years, 202 fetal tissue transplants have been performed in our department to treat 29 patients with severe inborn errors of metabolism without immunodeficiency, 26 patients with congenital and...

    J. -L. Touraine, S. Laplace, F. Rezzoug… in Journal of Inherited Metabolic Disease (1991)